Your email has been successfully added to our mailing list.

×
0.000242394861228894 0.000363592291843427 0.000121197430614533 0.000443582596048877 0.00109077687553028 0.00109077687553028 0.00109077687553028 0.00109077687553028
Stock impact report

Amicus Therapeutics Has Room To Fall Ahead [Seeking Alpha]

Sanofi - American Depositary Shares (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
Company Research Source: Seeking Alpha
Amicus Therapeutics Has Room To Fall AheadSummaryAmicus Therapeutics received approval from the FDA for their fabry disease treatment, Galafold.While FDA approvals are positive news, the approval only unlocks access to a specific corner of the market.Amicus announced pricing that is relatively high when compared to other options readily available to patients. High prices combined with a competitor like Sanofi raies concerns.All signs point to a dilutive offering and coming declines. Show less Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SNY alerts
Opt-in for
SNY alerts

from News Quantified
Opt-in for
SNY alerts

from News Quantified